Anika Therapeutics Inc. 5Y Operating CF Growth (CAGR)

5Y Operating CF Growth (CAGR) of ANIK for past 10 years: annual, quarterly and twelve month trailing (TTM) including 5Y Operating CF Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 5Y Operating CF Growth (CAGR) for 2021 was -16.33% (a -10.91% decrease from previous year)
  • Annual 5Y Operating CF Growth (CAGR) for 2020 was -18.33% (a 1789.69% increase from previous year)
  • Annual 5Y Operating CF Growth (CAGR) for 2019 was -0.97% (a -114.33% decrease from previous year)
Visit stockrow.com/ANIK for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 5Y Operating CF Growth (CAGR) of Anika Therapeutics Inc.

Most recent 5Y Operating CF Growth (CAGR)of ANIK including historical data for past 10 years.

Interactive Chart of 5Y Operating CF Growth (CAGR) of Anika Therapeutics Inc.

Anika Therapeutics Inc. 5Y Operating CF Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -16.33%
2020 -18.33%
2019 -0.97%
2018 6.77%
2017 31.07%
2016 19.52%
2015 22.44%
2014 0.98%
2013 -6.34%
2012 -23.71%
2011 -16.08%

Business Profile of Anika Therapeutics Inc.

Sector: Healthcare
Industry: Medical Devices